Dalbavancin Market: Antibiotic Stewardship and Treatment Innovation Outlook 2034
The Dalbavancin Market will continue to be shaped by infectious disease treatment needs, antimicrobial resistance trends, reimbursement conditions, and evidence supporting long-acting antibiotics. Responsible prescribing and reliable access will remain important factors in its development. The Dalbavancin Market size is expected to reach US$ 1,216.61 million by 2034 from US$ 615.05 million in...
0 التعليقات 0 المشاركات 249 مشاهدة 0 معاينة